Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Novel MS Drugs Advance
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Effirma, Synthetic Biologics
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
European School of Neuroimmunology 15th Course
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Keystone Symposium: Mechanisms of Pro-Inflammatory Diseases - joint with - Innate Immunity and Determinants of Microbial Pathogenesis
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Sleep and Cognitive Function in Multiple Sclerosis.
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
JOINT CONGRESS OF EUROPEAN NEUROLOGY
Episode 9 with Dr. Amit Bar-Or on how pediatric MS can illuminate early mechanisms of the disease
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.

Pages